TGTX position history
The shares of TG Therapeutics (TGTX) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q3: 1,890,000 shares, $16M, 5.1% of portfolio, New
- 2023 Q4: 2,215,000 shares, $38M, 10.1% of portfolio, Add +17.2%
- 2024 Q1: 4,560,000 shares, $69M, 15.5% of portfolio, Add +105.9%
- 2024 Q2: 2,280,000 shares, $41M, 9.3% of portfolio, Reduce −50.0%
- 2024 Q3: 2,280,000 shares, $53M, 8.9% of portfolio
- 2024 Q4: 2,260,000 shares, $68M, 11.9% of portfolio, Reduce −0.9%
- 2025 Q1: 535,000 shares, $21M, 4.7% of portfolio, Reduce −76.3%
- 2025 Q2: 1,070,000 shares, $39M, 7.8% of portfolio, Add +100.0%
- 2025 Q3: 535,000 shares, $19M, 2.7% of portfolio, Reduce −50.0%
- 2025 Q4: 1,070,000 shares, $32M, 4.2% of portfolio, Add +100.0%
- 2026 Q1: 535,000 shares, $18M, 2.3% of portfolio, Reduce −50.0%
- 2026 Q2: 535,000 shares, $29M, 2.7% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|